Intraarterially Administered Verapamil as Adjunct Therapy for Cerebral Vasospasm: Safety and 2-Year Experience

References

1. ↵
   Fisher CM, Roberson GH, Ojemann RG. Cerebral vasospasm with ruptured saccular aneurysm: the clinical manifestations. Neurosurgery 1977;1:245–248

   PubMed
2. ↵
   Eskridge JM, McAuliffe W, Song JK, et al. Balloon angioplasty for the treatment of vasospasm: results of first 50 cases. Neurosurgery 1998;42:510–517

   CrossRefPubMedWeb of Science
3. Higashida RT, Halbach VV, Dowd CF, Dormandy B, Bell J, Hieshima GB. Intravascular balloon dilatation therapy for intracranial arterial vasospasm: patient selection, technique, and clinical results. Neurosurg Rev 1992;15:89–95

   CrossRefPubMedWeb of Science
4. Zubkov YN, Nikiforov BM, Shustin VA. Balloon catheter technique for dilatation of constricted cerebral arteries after aneurysmal SAH. Acta Neurochir (Wien) 1984;70:65–79
5. ↵
   Firlik AD, Kaufmann AM, Jungreis CA, Yonas H. Effect of transluminal angioplasty on cerebral blood flow in the management of symptomatic vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 1997;86:830–839

   PubMedWeb of Science
6. ↵
   Park KW, Metais C, Dai HB, Comunale ME, Sellke FW. Microvascular endothelial dysfunction and its mechanism in a rat model of subarachnoid hemorrhage. Anesth Analg 2001;92:990–996

   CrossRefPubMedWeb of Science
7. ↵
   Takayasu M, Bassett JE, Dacey RG. Effects of calcium antagonists on intracerebral penetrating arterioles in rats. J Neurosurg 1988;69:104–109

   PubMedWeb of Science
8. Meyer FB. Calcium antagonists and vasospasm. Neurosurg Clin N Am 1990;1:367–376

   PubMed
9. ↵
   Yundt KD, Grubb RL Jr, Diringer MN, Powers WJ. Autoregulatory vasodilation of parenchymal vessels is impaired during cerebral vasospasm. J Cereb Blood Flow Metab 1998;18:419–424

   CrossRefPubMedWeb of Science
10. ↵
    Katoh H, Shima K, Shimizu A, et al. Clinical evaluation of the effect of percutaneous transluminal angioplasty and intra-arterial papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. Neurol Res 1999;21:195–203

    PubMed
11. ↵
    Firlik KS, Kaufmann AM, Firlik AD, Jungreis CA, Yonas H. Intra-arterial papaverine for the treatment of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Surg Neurol 1999;51:66–74

    CrossRefPubMed
12. Polin RS, Hansen CA, German P, Chadduck JB, Kassell NF. Intra-arterially administered papaverine for the treatment of symptomatic cerebral vasospasm. Neurosurgery 1998;42:1256–1267

    CrossRefPubMedWeb of Science
13. ↵
    Elliott JP, Newell DW, Lam DJ, et al. Comparison of balloon angioplasty and papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 1998;88:277–284

    PubMedWeb of Science
14. ↵
    Livingston K, Guterman LR, Hopkins LN. Intraarterial papaverine as an adjunct to transluminal angioplasty for vasospasm induced by subarachnoid hemorrhage. AJNR Am J Neuroradiol 1993;14:346–347

    Abstract/FREE Full Text
15. ↵
    Numaguchi Y, Zoarski GH. Intra-arterial papaverine treatment for cerebral vasospasm: our experience and review of the literature. Neurol Med Chir (Tokyo) 1998;38:189–195
16. ↵
    Tsurushima H, Kamezaki T, Nagatomo Y, Hyodo A, Nose T. Complications associated with intraarterial administration of papaverine for vasospasm following subarachnoid hemorrhage: two case reports. Neurol Med Chir (Tokyo) 2000;40:112–115
17. Barr JD, Mathis JM, Horton JA. Transient severe brain stem depression during intraarterial papaverine infusion for cerebral vasospasm. AJNR Am J Neuroradiol 1994;15:719–723

    Abstract/FREE Full Text
18. ↵
    McAuliffe W, Townsend M, Eskridge JM, Newell DW, Grady MS, Winn HR. Intracranial pressure changes induced during papaverine infusion for treatment of vasospasm. J Neurosurg 1995;83:430–434

    PubMedWeb of Science
19. ↵
    Fogarty-Mack P, Pile-Spellman J, Hacein-Bey L, et al. Superselective intraarterial papaverine administration: effect on regional cerebral blood flow in patients with arteriovenous malformations. J Neurosurg 1996;85:395–402

    PubMed
20. Joshi S, Hashimoto T, Ostapkovich N, et al. Effect of intracarotid papaverine on human cerebral blood flow and vascular resistance during acute hemispheric arterial hypotension. J Neurosurg Anesthesiol 2001;13:146–151

    PubMedWeb of Science
21. ↵
    Vajkoczy P, Horn P, Bauhuf C, et al. Effect of intra-arterial papaverine on regional cerebral blood flow in hemodynamically relevant cerebral vasospasm. Stroke 2001;32:498–505

    Abstract/FREE Full Text
22. ↵
    Ghani GA, Sung YF, Weinstein MS, Tindall GT, Fleischer AS. Effects of intravenous nitroglycerin on the intracranial pressure and volume pressure response. J Neurosurg 1983;58:562–565

    PubMed
23. ↵
    Pluta RM, Afshar JK, Thompson BG, Boock RJ, Harvey-White J, Oldfield EH. Increased cerebral blood flow but no reversal or prevention of vasospasm in response to 𝓁-arginine infusion after subarachnoid hemorrhage. J Neurosurg 2000;92:121–126

    PubMed
24. ↵
    Allen GS, Ahn HS, Preziosi TJ, et al. Cerebral arterial spasm: a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med 1983;308:619–624

    CrossRefPubMedWeb of Science
25. ↵
    Petruk KC, West M, Mohr G, et al. Nimodipine treatment in poor-grade aneurysm patients: results of a multicenter double-blind placebo-controlled trial. J Neurosurg 1988;68:505–517

    PubMedWeb of Science
26. ↵
    Taniyama Y, Ito H, Iwakura K, et al. Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction. J Am Coll Cardiol 1997;30:1193–1199

    CrossRefPubMedWeb of Science
27. Babbitt DG, Perry JM, Forman MB. Intracoronary verapamil for reversal of refractory coronary vasospasm during percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1988;12:1377–1381

    PubMedWeb of Science
28. ↵
    Pomerantz RM, Kuntz RE, Diver DJ, Safian RD, Baim DS. Intracoronary verapamil for the treatment of distal microvascular coronary artery spasm following PTCA. Cathet Cardiovasc Diagn 1991;24:283–285

    PubMedWeb of Science
29. ↵
    Joshi S, Young WL, Pile-Spellman J, et al. Manipulation of cerebrovascular resistance during internal carotid artery occlusion by intraarterial verapamil. Anesth Analg 1997;85:753–759

    PubMedWeb of Science
30. ↵
    Joshi S, Young WL, Pile-Spellman J, et al. Intra-arterial nitrovasodilators do not increase cerebral blood flow in angiographically normal territories of arteriovenous malformation patients. Stroke 1997;28:1115–1122

    Abstract/FREE Full Text
31. ↵
    Bauer JH, Reams GP. The role of calcium entry blockers in hypertensive emergencies. Circulation 1987 :75(6 Pt 2):V174–V180
32. ↵
    Krebs R. Adverse reactions with calcium antagonists. Hypertension 1983;5(4 Pt 2):II125–II129
33. ↵
    Bedford RF, Dacey R, Winn HR, Lynch C III. Adverse impact of a calcium entry-blocker (verapamil) on intracranial pressure in patients with brain tumors. J Neurosurg 1983;59:800–802

    PubMed
34. ↵
    Thiagarajah S, Azar I, Lear E, Albert D. Intracranial pressure changes during infusions of verapamil as compared with sodium nitroprusside. Bull N Y Acad Med 1985;61:650–656

    PubMed
35. Dietrich HH, Dacey RG Jr. Molecular keys to the problems of cerebral vasospasm. Neurosurgery 2000;46:517–530

    PubMedWeb of Science
36. ↵
    Cheymol G. Clinical pharmacokinetics of drugs in obesity: an update. Clin Pharmacokinet 1993;25:103–114

    PubMedWeb of Science